We’re hours away from entering 2022, and the world has been through the COVID pandemic for about two years now. Each and every one of us has been affected in one way or another by the coronavirus pandemic. Hopefully, things will become better in 2022, and recent news seems to point towards such a scenario.
Reuters reveals that the antiviral COVID pill known as Paxlovid developed by Pfizer received approval in Britain. It’s great that individuals going through a mild to moderate form of COVID can benefit from the drug. However, another condition for them in order to take the drug is to be at risk of their illness worsening.
You should take Paxlovid during the early stages of COVID
Taking Pfizer’s Paxlovid pill is also extremely easy. The patient will just need to swallow the medication, which is indeed more comfortable than an injection with a needle. You’d be surprised by how many people are afraid of needles!
One thing’s for sure: it’s easy to mistake your early COVID symptoms for a usual cold or flu. And it’s tempting to just not test yourself and hope that it’s not the coronavirus attacking your body. Hoping that nobody will take too lightly such symptoms, taking Pfizer’s antiviral pill in the early stages of COVID will grant the most beneficial effects.
June Raine, the chief of Britain’s Medicines and Healthcare products Regulatory Agency (MHRA), declared:
We now have a further antiviral medicine for the treatment of COVID-19 that can be taken by mouth rather than administered intravenously. This means it can be administered outside a hospital setting.
However, a recent news from NBCNews.com explains why taking Pfizer’s pill can actually be a bad idea in some situations, like combining it with other medications.
We’re eagerly looking forward to seeing how the world will receive Pfizer’s pill for treating COVID.
